Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

TBC1D22A Activators

TBC1D22A is a protein encoded by the TBC1D22A gene in humans. Its name reflects its classification: TBC1 indicates that it contains a TBC (Tre-2, Bub2, and Cdc16) domain, which is typically associated with proteins that have GTPase-activating protein (GAP) activity towards small GTPases of the Rab family. The 'D22A' suffix denotes its specific gene identifier within this family.Proteins in this group, including TBC1D22A, are regulators of intracellular vesicle trafficking. They function by inactivating Rab GTPases, which play critical roles in directing vesicle transport along cytoskeletal tracks to different cellular compartments such as the Golgi apparatus, endosomes, lysosomes, and the plasma membrane. By acting as GAPs, TBC domain-containing proteins like TBC1D22A help control the timing of vesicle fusion and release, ensuring that cargo is delivered to the correct location within the cell.

The TBC1D22A protein may have specific substrates among the Rab GTPases, although the precise Rab targets and the pathways that TBC1D22A regulates are not well-characterized compared to other members of the TBC domain-containing protein family. It is likely involved in processes such as membrane trafficking, signal transduction, and cellular growth and differentiation.Mutations or dysregulation of proteins that control vesicle trafficking, like TBC1D22A, can lead to a wide array of cellular dysfunctions and are often implicated in diseases including neurological disorders, cancer, and metabolic syndromes.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Brefeldin A disrupts Golgi apparatus function and could indirectly affect TBC1D22A-related Rab GTPase activity.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Nocodazole disrupts microtubule dynamics, affecting vesicular transport and potentially TBC1D22A function.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin, by elevating cAMP levels, can modulate various signaling pathways, possibly influencing TBC1D22A.

9-[5-Deoxy-5-[[cis-3-[2-[6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl]ethyl]cyclobutyl](1-methylethyl)amino]-β-D-ribofuranosyl]-9H-purin-6-amine

1380288-87-8sc-500607
50 mg
$13500.00
(0)

ML141 is a Cdc42 inhibitor, potentially impacting pathways that intersect with TBC1D22A-related Rab GTPase activity.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$151.00
$609.00
75
(4)

NSC23766 inhibits Rac1, which might have downstream effects on cellular processes involving TBC1D22A.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Cytochalasin D disrupts actin filaments, affecting cell morphology and transport, potentially impacting TBC1D22A.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a PI3K inhibitor, influencing vesicle trafficking and possibly TBC1D22A function.

YM201636

371942-69-7sc-204193
5 mg
$217.00
6
(1)

YM201636 inhibits PIKfyve, affecting endosomal trafficking, potentially relevant for TBC1D22A activities.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Dynasore inhibits dynamin, affecting endocytosis and vesicular trafficking, potentially relevant for TBC1D22A.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine, affecting endosomal and lysosomal function, may have implications for TBC1D22A-related processes.